or Try an Advanced Search...

    Technical Analysis for GRTX - Galera Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.20 10.11% 0.02
    GRTX closed up 10.11 percent on Friday, May 24, 2024, on 44 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical GRTX trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Crossed Above 200 DMA Bullish 0.00%
    Crossed Above 50 DMA Bullish 0.00%
    Golden Cross Bullish 0.00%
    180 Bullish Setup Bullish Swing Setup 0.00%
    BB Squeeze Ended Range Expansion 0.00%
    Outside Day Range Expansion 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    50 DMA Resistance Bearish 10.11%
    Fell Below 20 DMA Bearish 10.11%
    Older End-of-Day Signals for GRTX ...

       Recent Intraday Alerts

    Alert Time
    200 DMA Resistance 3 days ago
    Upper Bollinger Band Resistance 3 days ago
    Rose Above Previous Day's High 3 days ago
    Rose Above Upper Bollinger Band 3 days ago
    Rose Above 200 DMA 3 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    GRTX Chart by TradingView
    Basic chart:

    Profile

    Galera Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Radiation Radiation Therapy DSL Fibrosis Treatment Of Fibrosis Mucositis

    Is GRTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 Galera Therapeutics GAAP EPS of -$0.08
    May 13 Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates
    May 3 Galera Adopts Limited Duration Stockholder Rights Agreement
    Apr 1 Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
    Mar 28 Galera Therapeutics GAAP EPS of -$0.10
    Mar 28 Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
    Feb 27 Galera Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying
    Jan 21 Galera Therapeutics Insiders Lose Out As Stock Sinks To US$0.17
    Jan 9 Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    See more GRTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.59
    52 Week Low 0.0853
    Average Volume 1,728,211
    200-Day Moving Average 0.18
    50-Day Moving Average 0.19
    20-Day Moving Average 0.18
    10-Day Moving Average 0.19
    Average True Range 0.02
    RSI (14) 55.56
    ADX 13.36
    +DI 28.00
    -DI 19.09
    Chandelier Exit (Long, 3 ATRs) 0.18
    Chandelier Exit (Short, 3 ATRs) 0.21
    Upper Bollinger Bands 0.20
    Lower Bollinger Band 0.17
    Percent B (%b) 0.89
    BandWidth 16.39
    MACD Line 0.00
    MACD Signal Line 0.00
    MACD Histogram 0.0009
    Fundamentals Value
    Market Cap 10.66 Million
    Num Shares 54.4 Million
    EPS -1.88
    Price-to-Earnings (P/E) Ratio -0.10
    Price-to-Sales 0.00
    Price-to-Book 29.39
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.23
    Resistance 3 (R3) 0.23 0.21 0.23
    Resistance 2 (R2) 0.21 0.21 0.22 0.22
    Resistance 1 (R1) 0.21 0.20 0.21 0.21 0.22
    Pivot Point 0.19 0.19 0.19 0.19 0.19
    Support 1 (S1) 0.18 0.18 0.19 0.18 0.17
    Support 2 (S2) 0.17 0.18 0.17 0.17
    Support 3 (S3) 0.16 0.17 0.17
    Support 4 (S4) 0.16